The independent source for health policy research, polling, and news.
1,941-1,960 of 1,961 results
This immunization may mark a shift among some vaccine makers to higher-priced, ānicheā preventives that protect against very specific and sometimes rare illnesses.
In this episode of āWhat the Health?ā Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times discuss the potential health impact of Hurricane Harvey on the Texas Gulf Coast, and what impact the relief effort in Washington could have on an already jampacked September agenda. Also this week: an interview with Elisabeth Rosenthal about why medical care costs so much.
In this Facebook Live, KHNās Julie Appleby talks with Stephanie Stapleton and answers readersā questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.
Three-quarters of participants in a newly released study said they did not know of resources for comparing health care costs, while half said that if a website were available to provide such information, they would use it.
The number of Americans with high-deductible health plans is growing, along with the fear that even insured people wonāt get the care they need because itās too costly.
For pregnant women in the United States, Medicaid is less a safety net than a building block of the maternity care system.
A coalition of health care providers are blocking Ohioās law requiring health care providers to tell what non-emergency services will cost them.
Tennessee and Virginia regulators are considering approval of a merger between Mountain States Health Alliance and Wellmont Health System under their state laws. If they allow it, the Federal Trade Commission would be powerless to stop it.
The controversial 340B drug discount program for hospitals came under fire at a congressional hearing.
Some health plans are beginning to offer free maintenance care for people with chronic health problems, hoping that spending a little more early on will save a lot of money in the long run.
A little-noticed provision in President Donald Trumpās executive order on drug prices may offer a clue to why Big Pharma hasnāt opposed a bill that could bleed their balance sheets of millions of patients.
The bill would limit non-economic damages to $250,000, but it faces opposition from across the political spectrum.
Critics point to the stateās aggressive eligibility checks as an example of what can go wrong when states have flexibility and add a reason to worry about GOP efforts to overhaul the program.
One of two insurers in this tiny state has announced it will not be back in the marketplaces next year, leaving customers concerned about the prices they will pay.
A study in Health Affairs shows that people who receive federal housing vouchers and other forms of public housing assistance are more likely to have health insurance and get regular medical care.
In states that take up the billās option to change the essential health benefits, the out-of-pocket spending limits and annual and lifetime caps on coverage in large group plans could fray.
With limited federal subsidies under the GOP health care bill, experts say states like California and New York would be under pressure to cut costs. That could mean shrinking benefits and dropping the prohibition against charging sicker patients higher premiums.
California has reported more than 500 travel-related Zika infections, and five babies have been born in the state with birth defects related to the mosquito-borne disease.
Democrats want a bill to fund the government for the rest of the year to include funding for the health lawās cost-sharing reductions for low-income marketplace customers, but Republicans want to keep the issues separate.
Out-of-pocket costs can rise dramatically for children with chronic health issues if a family changes marketplace coverage, according to a new study.
Ā© 2026 KFF